The vaccine was 72% effective in the U.S.-based portion of a global study that enrolled more than 43,000 people,
The shot was highly effective against severe disease in all regions where it was tested and worked better against mutant coronavirus strains than previously reported, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.